Journal Watch - AWAK
Safety and Efficacy of Wearable PD
The automated wearable artificial kidney (AWAK) uses sorbent technology. In a pilot study done in Singapore, patients used the AWAK for 72 hours and were followed up for a month. Among the 15 patients who took part, the AWAK had to be altered to fix blocked flows, but no serious adverse events occurred. Abdominal pain (60%) and bloating (47%) were reported.
Read the abstract » | (added 2022-07-13)